Ristocetīna trombocītu agregācijas reaģents — RIPA / vWF:RCo (3 × 7,5 mg)

Tikai pētniecības nolūkos. Nelietot diagnostikas procedūrās.

Ristocetin reagent for Light Transmission Aggregometry (LTA) platelet function testing. 3x7.5 mg. For Ristocetin-Induced Platelet Aggregation (RIPA). Essential for von Willebrand disease (vWD) screening — ristocetin requires vWF to agglutinate platelets. Low RIPA = vWD suspected. High-dose (1.5 mg/mL) for standard RIPA; low-dose (0.5 mg/mL) to detect Type 2B vWD (enhanced RIPA at low dose). CE-IVD.